Sort
30,917 grants matching “tumor microenvironment”
Tumor Cell-Intrinsic/Extrinsic Mechanisms Underlying Myeloma Disease Progression
$363,713Diane F Jelinek · Mayo Clinic Rochester · R01 · FY2018 · CA
Monocyte promotion of therapy resistance by immune and non-immune mechanisms
$363,713Yi Lin · Mayo Clinic Rochester · R01 · FY2020 · CA
Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches
$363,685Keith Syson Chan · Methodist Hospital Research Institute · R01 · FY2024 · CA
Project 4- Targeting the neuronal microenvironment in gliomas (Monje/Suva)
$363,681Mario Luca Suva · Brigham And Women'S Hospital · P50 · FY2019 · CA
Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer.
$363,672Tracy L McGaha · University Health Network · R01 · FY2023 · CA
Role of acetyl-CoA in linking cancer cell metabolism and epigenetics
$363,669Kathryn Elaine Wellen · University Of Pennsylvania · R01 · FY2024 · CA
Role of hematopoietic microenvironment in plexiform neurofibroma progression
$363,662David W. Clapp · Ut Southwestern Medical Center · P50 · FY2012 · NS
Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells
$363,583Jenny Zilberberg · Hackensack University Medical Center · R33 · FY2017 · CA
Lipids and Myeloid Cell Function in Cancer
$363,568Dmitry Isaac Gabrilovich · Wistar Institute · R01 · FY2016 · CA
Measuring extracellular pH in pre-clinical tumor models with CEST MRI
$363,512Mark David Pagel · University Of Arizona · R01 · FY2013 · CA
A NEW PARADIGM FOR SIMULTANEOUS IMMUNOMODULATION OF THE TUMOR MICROENVIRONMENT AND DIRECT OVARIAN CANCER CELL ERADICATION USING B7-H4-BASED TARGETING
$363,460Trustees Of The University Of Pennsylvania, The · · FY2012 · Department of Defense
MOLECULAR MECHANISMS OF TUMOR-INDUCED TOLERANCE
$363,450Lieping Chen · Johns Hopkins University · R01 · FY2007 · CA
MOLECULAR MECHANISMS OF TUMOR-INDUCED TOLERANCE
$363,450Lieping Chen · Johns Hopkins University · R01 · FY2009 · CA
MOLECULAR MECHANISMS OF TUMOR-INDUCED TOLERANCE
$363,450Lieping Chen · Johns Hopkins University · R01 · FY2010 · CA
Expanding the Therapeutic Window of Nanoparticle STING Agonists for Cancer Immunotherapy
$363,450John Tanner Wilson · Vanderbilt University · R01 · FY2020 · CA
MOLECULAR MECHANISMS OF TUMOR-INDUCED TOLERANCE
$363,450Lieping Chen · Johns Hopkins University · R01 · FY2008 · CA
Multi-Scale Cancer Modeling: From Cell Phenotypes to Cancer Spread and Response
$363,394Vittorio Cristini · University Of Southern California · U54 · FY2011 · CA
Computational methods for in situ spatial transcriptomics
$363,384Zhicheng Ji · Duke University · R35 · FY2024 · GM
Targeting the vasculature to enhance anti-tumor immunity
$363,375Andrew Carl Dudley · University Of Virginia · R01 · FY2020 · CA
Targeting the vasculature to enhance anti-tumor immunity
$363,375Andrew Carl Dudley · University Of Virginia · R01 · FY2021 · CA
New protein engineering-based tools and technologies for characterizing cell surface proteolysis in cancer cells for novel neo-epitope biomarkers and drug targets
$363,351James A Wells · University Of California, San Francisco · R01 · FY2021 · CA
Correlates of antitumor immunity in colorectal cancers and anti PD1 therapy
$363,340Franck Housseau · Johns Hopkins University · R01 · FY2019 · CA
The role of chronic stress in regulation of mutant p53 and tumorigenesis
$363,306Wenwei Hu · Rbhs -Cancer Institute Of New Jersey · R01 · FY2021 · CA
The role of chronic stress in regulation of mutant p53 and tumorigenesis
$363,306Wenwei Hu · Rbhs -Cancer Institute Of New Jersey · R01 · FY2017 · CA
The role of chronic stress in regulation of mutant p53 and tumorigenesis
$363,306Wenwei Hu · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA